A city-based company is under investigation for defective eye drops sold in the US.
What’s it about? Global Health’s lubricant eye drops distributed by Ezricare and Delsam Pharma in the US are being investigated by the Centre for Disease Control and Prevention. Officials noted 55 adverse cases, including permanent blindness and one death. They attributed this to the eye drops.
- The drops in question aren’t sold in India. The US FDA has asked doctors and consumers not to buy the product. The company is now on the FDAs import alert list to prevent future imports.
- The FDA has issued a notification to recall the drops from the market, citing manufacturing violations like lack of microbial testing and proper controls for tamper-evident packaging.
Domestic reaction: Following the FDA warning, drug inspectors from the Centre and the Tamil Nadu government searched the company’s premises 40 km south of Chennai.